Search Within

Computational Oncology Service

  1. "Biostatistics Service"
Formats
  1. Journal Article (165)
  2. Meeting Abstract (60)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Biostatistics Service (228)
  2. Epidemiology and Biostatistics (228)
  3. GSK Faculty (216)
  4. Department of Medicine (194)
  5. Human Oncology and Pathogenesis Program (194)
  6. Solid Tumor Oncology Division (169)

More Groups

People
  1. Nikolaus Schultz (148)
  2. Michael Berger (70)
  3. David Solit (67)
  4. Francisco Sanchez Vega (49)
  5. Marc Ladanyi (49)
  6. Jianjiong Gao (38)

More People

Years
  1. 2025 (10)
  2. 2024 (20)
  3. 2023 (22)
  4. 2022 (30)
  5. 2021 (23)
  6. 2020 (24)

More Years

Publications
  1. Journal of Clinical Oncology (32)
  2. Clinical Cancer Research (21)
  3. Blood (14)
  4. Nature (14)
  5. Cancer Discovery (11)
  6. Cancer Research (11)

More Publications

Publishers
  1. American Association for Cancer Research (45)
  2. American Society of Clinical Oncology (37)
  3. Nature Publishing Group (35)
  4. American Society of Hematology (17)
  5. Oxford University Press (16)
  6. Cell Press (15)

More Publishers

Results (228)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • FOLFCIS regimen for treatment of cancer of the anal canal
    Meeting Abstract

    Mondaca, S.; Chatila, W. K.; Hechtman, J. F.; Bates, D.; Cercek, A.; Segal, N. H.; Stadler, Z. K.; Varghese, A. M.; Berger, M. F.; Capanu, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver
    Meeting Abstract

    Dong, Y.; Ganly, I.; Makarov, V.; Kuo, F.; Deraje, S.; Reznik, E.; Seshan, V.; Nanjangud, G.; Morris, L.; Riaz, N.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • V(D)J sequence capture for DNA-based minimal residual disease detection in multiple myeloma
    Meeting Abstract

    Rustad, E. H.; Hultcrantz, M.; Yellapantula, V. D.; Akhlaghi, T.; Ho, C.; Arcila, M. E.; Roshal, M.; Patel, A.; Devlin, S. M.; Jacobsen, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Integrative molecular characterization of malignant pleural mesothelioma
    Journal Article

    Hmeljak, J.; Sanchez-Vega, F.; Hoadley, K. A.; Shih, J.; Stewart, C.; Heiman, D.; Tarpey, P.; Danilova, L.; Drill, E.; Gibb, E. A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the Hippo pathway
    Journal Article

    Li, Z.; Razavi, P.; Li, Q.; Toy, W.; Liu, B.; Ping, C.; Hsieh, W.; Sanchez-Vega, F.; Brown, D. N.; Da Cruz Paula, A. F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save